Expanded Access for Relatlimab
NCT05170659
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Interventions
DRUG:
Relatlimab
Sponsor
Bristol-Myers Squibb